Magnetics Business & Technology - September/October 2022 - 20

RESEARCH & DEVELOPMENT
Neutron Therapeutics' Precision Cancer-Treatment Systems Entering Medical Centers
Neutron Therapeutics' nuBeam suite at Helsinki University Hospital in Finland
Neutron Therapeutics, the brainchild of electromagnetic engineering
entrepreneur Bill Buckley of New Zealand, is meeting with
new success placing its equipment for ultra-precision treatment
of cancer cells and for advanced neutron sources into hospitals
and medical research environments. Its revolutionary nu-Beam
systems are finding homes at Helsinki University Hospital and the
University Hospital of Brussels while its latest high flux neutron
source is being installed at the University of Birmingham where it
will become part of the UK's National Nuclear User Facility.
Neutron has been developing a comprehensive solution for Boron
Neutron Capture Therapy (BNCT), a targeted radiation cancer
therapy in which neutron beams destroy only boron compoundbearing
tumors without destroying neighboring normal tissue.
BNCT has the potential to deliver highly effective and cell-localized
radiation therapy to treat tumors with minimal impact on the
patient's quality of life compared to other radiation, chemotherapy
or biological treatment modalities currently in use.
BNCT is an emerging, biologically-targeted form of radiotherapy
that destroys tumor cells with minimal impact to surrounding
healthy cells. It has the potential to revolutionize radiation oncology,
having demonstrated compelling success in some of the
most difficult-to-treat cancers and in treating patients for whom all
other treatment options have been exhausted.
Bill Buckley, co-founder
and chairman of
Neutron Therapeutics
& founder of Buckley
Systems
Headquartered in Danvers, Massachusetts
near Boston, Neutron was founded in 2015.
Its chairman and co-founder, Buckley, is
also founder of Buckley Systems Ltd. in
New Zealand which has been a leader in
producing advanced electromagnetic equipment
for scientific and industrial use around
the world. From concept to " first beam " ,
Buckley Systems provides end-to-end design,
engineering and integration solutions
for magnetic systems with an emphasis on
its precision manufacturing capability.
Buckley Systems in New Zealand is renowned for manufacturing
precision electromagnets, from large spectrometer and analyser
magnets weighing tens of tons to quadrupole magnets weighing less
than a kilogram.
Reportedly, he has devoted a significant portion of his wealth,
estimated at more than $100 million, to help support Neutron as
it applies his engineering vision to the development of precision
systems for treating cancer and for medical research.
Neutron's flagship product, nuBeam, shown in the top photo, is a
high-throughput, compact accelerator-based neutron source suitable
for clinical settings, able to replace legacy nuclear reactors.
It has the highest neutron flux of all currently available BNCT systems
and is the only device producing an IAEA-compliant BNCT
beam for the safe and effective clinical use of neutrons.
The first simulated patient treatment using nuBeam was carried
out recently at Helsinki University Hospital. Finland has been a
European hotspot of BNCT trials since 1992. With the ongoing
clinical verification and validation testing of the nuBeam system at
20 Magnetics Business & Technology * September/October 2022
www.MagneticsMag.com
http://www.MagneticsMag.com
Magnetics Business & Technology - September/October 2022

Table of Contents for the Digital Edition of Magnetics Business & Technology - September/October 2022
